LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 2,440 pages found matching data breach- Ezetrol: Canadian Version of Zetia Questioned
Mar-9-08 Toronto, ON As if the Zetia and Vytorin issue wasn't enough of a frustration on its own, north of the border in Canada the Canadian equivalent of Zetia— Ezetrol —is proving just as mystifying. At issue: does the cholesterol drug work? Is it harmful? And did the manufacturer, as it was accused of doing in the US, withhold important safety a... - Faulty Railing Results in Crib Recall
Mar-1-08 Washington, DC: A massive crib recall was issued on Thursday by safety officials and they warned parents that they should not put their babies in their beds with soft bedding such as pillows due to the risk of suffocation. A total of 24,000 cribs made in Indonesia were recalled due to a high risk of children falling out . Imported by Munire Furniture... - Daniel Troy - Bush Administration's Preemption Gang - Part II
Feb-26-08 Washington, DC: In the fall of 2004, Daniel Troy left the FDA armed with the preemption policy he put in place. Now a partner at Sidley Austin Brown & Wood, Mr Troy works for a firm that he told Lily Henning of the Legal Times on September 20, 2005, "represents pretty much almost every company" in the brand-name drug industry. In fact, Sidley Austin i... - Daniel Troy - Bush Administration's Preemption Gang - Part I
Feb-25-08 Washington, DC: Judging by the line-up of current and former Bush Administration attorneys representing the pharmaceutical industry against private citizens in courts all over the country, no conflict-of-interest regulations apply to attorneys who work for Bush. The self-identified primary author of the preemption language in the new drug labeling rul... - Botox: Lose the Wrinkles, Lose Your Life?
Feb-22-08 Washington, DC Got a Botox shot lately, to mitigate those wrinkles? Here's the thing—Botox could actually provide one little wrinkle of its own: You could die from it . Earlier this month the US Food and Drug Administration (FDA) was petitioned by the advocacy group Public Citizen to release warnings about Botox, a product that is more generall... - FDA Renews Concerns Regarding Botox and Death
Feb-21-08 Hollywood, CA: The FDA is now renewing their concerns regarding the risk of death and other health issues that can arise as a result of using Botox. This renewed concern comes after the group Public Citizen, based out of Washington, asked the FDA to place the strongest possible black box warning on the Allergan company's very popular anti-aging product. It... - Nearly a Third of Bypass Patients Given Trasylol
Feb-21-08 Seattle, WA: It has been found that Trasylol was given to as many as one-third of U.S. patients who had undergone heart bypass or comparable surgery before the November 2007 recall of the drug, according to researcher Dr. Dennis Mangano. Approved by the FDA in 1993, Trasylol is used to reduce bleeding during heart bypass surgery by blocking the enzyme... - Asbestos: Remove? Or Leave Well Enough Alone?
Feb-15-08 Washington, DC: There is a myth out there about asbestos. Oh, it's a health hazard all right, and as a known carcinogen it can cause asbestos mesothelioma . However, the popular belief that if you have asbestos in your building you've got to get it out of there, could be flawed. In fact, many experts agree that it is best, provided asbestos is properly... - California Labor Law: Verbal Abuse leads to Personal Injury
Feb-14-08 Jose, CA Lisa D. put up with verbal abuse and harassment from her manager for two years. The situation got so out of control that she it now on disability. "I was making $16 per hour and I'm not sure yet what percentage I will get on disability," says Lisa, "but I'll be able to pull through this, as long as I am secure in knowing I have a job to go back... - Public Health Advisory Issued by FDA on Chantix
Feb-7-08 Rockville, MD: A Public-Health Advisory has been issued by the US Food and Drug Administration to caregivers, health care providers, and patients regarding new warnings that concern the stop smoking prescription medication, Chantix . An Early Communication was issued to health care providers and the public by the FDA on November 20, 2007, regarding the... - Suicides by Chantix Users Prompt FDA Advisory
Feb-3-08 Rockville, MD: Serious neuropsychiatric symptoms have occurred in patients taking Chantix (Varenicline). These symptoms include changes in behavior, agitation, depressed mood, suicidal ideation, and attempted and completed suicide , according to a Public Health Advisory issued February 1, 2008 by the U.S. Food and Drug Administration (FDA). The FDA i... - Zetia/Vytorin: What Did They Know and When Did They Know It?
Feb-3-08 Kenilworth, NJ: The scandal over Merck/Schering-Plough's long delay in releasing the results of the ENHANCE tests of its big-bucks anti-cholesterol medication Vytorin continues to grow—to the extent that The Wall Street Journal now calls it "Vytoringate". And like its predecessor scandal, the focus of investigations has come down to a simple question: Wh... - Zetia/Vytorin Manufacturers Pull TV Ads
Jan-24-08 Kenilworth, NJ: Merck/Schering-Plough announced on Tuesday January 22, that they are pulling all direct-to-consumer (DTC) television advertisements for their Zetia and Vytorin products. Zetia is Merck/Schering's branded anti-cholesterol drug which is also used in Vytorin, which contains Zetia and the statin drug Zocor (simvastation). Merck/Schering's... - Trasylol: 235 Deaths. Are There More?
Jan-11-08 Washington, DC: While the world waits for the results of the now-halted Canadian BART study on the effects of anti-bleeding drug Trasylol , various reports of deaths linked to Trasylol lend new emphasis of the wisdom in taking a considered pause, before Trasylol is allowed back on the market. That last statement is a question mark, as the US Food and D... - Medtronic Sprint Fidelis Leads: No Easy Answers
Jan-6-08 Miami, FL: Patients who have had Medtronic Sprint Fidelis Leads implanted are starting to realize that when it comes to what they should do about the leads, there are no easy answers. This is especially true of patients who have not yet experienced defibrillator failure because of fractured leads. Those patients are told that they should not have the lea... - Zetia can have Serious Side Effects
Jan-5-08 Seattle, WA: Patients taking Zetia are now learning that the drug may come with some serious side effects. Those include liver damage, rhabdomyolysis and myopathy. What has surprised many consumers is that the makers of Zetia conducted a few studies and found that there are risks associated with taking Zetia, but did not publicize the results of those st... - Zetia: Feds Order Early Release of Enhance Trial Data
Jan-4-08 Whitehouse Station, NJ: A study into the effectiveness of cholesterol drug Zetia completed months ago may shed new light on the true effectiveness of the Shering-Plough and Merck product, and the potential for liver damage. However, the manufacturer has been dragging its heels, so much so that the investigations subcommittee of the House Energy and Comme... - Preemption - Bush Administration Tag-Team Argues for Medtronic Part II
Jan-3-08 Washington, DC: Persuading the US Supreme Court to rule against the private citizen in the case of Medtronic v Riegel would represent the ultimate parting gift to the device industry from the neutered duck in the White House, because a ruling by the nation's highest court cannot be undone. In the words of Ted Olson, the Bush Administration's Former Soli... - Medtronic Fidelis lead: a Nightmare for Patients
Dec-13-07 Morristown, NJ Since Medtronic announced a recall of defective Fidelis leads back in October, pacemaker and defibrillator patients have been handed a dilemma that is nothing short of a nightmare: will the lead fail? Some patients are filing lawsuits against Medtronic, whether or not they have failed. Sometimes, not knowing is cruel punishment. Fi... - Avandia: Yet Another Nail in the Coffin
Dec-12-07 Toronto, ON: A Canadian study, released yesterday, suggests that for every 100 people taking diabetes drug Avandia over a four-year period—five will die, four will suffer a heart attack and three more will experience heart failure. In response, the US Food and Drug Administration (FDA) is standing pat. The study, originating at the Institute for...